• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于乳酸代谢相关长链非编码RNA的食管鳞状细胞癌患者风险特征识别

Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma.

作者信息

Zhao Fangchao, Li Yishuai, Dong Zefang, Zhang Dengfeng, Guo Pengfei, Li Zhirong, Li Shujun

机构信息

Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Department of Thoracic Surgery, Hebei Chest Hospital, Shijiazhuang, China.

出版信息

Front Cell Dev Biol. 2022 May 12;10:845293. doi: 10.3389/fcell.2022.845293. eCollection 2022.

DOI:10.3389/fcell.2022.845293
PMID:35646892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9134121/
Abstract

Lactic acid, formerly thought of as a byproduct of glycolysis or a metabolic waste produced, has now been identified as a key regulator of cancer growth, maintenance, and progression. However, the results of investigations on lactic acid metabolism-related long non-coding RNAs (LRLs) in esophageal squamous cell carcinoma (ESCC) remain inconclusive. In this study, univariate Cox regression analysis was carried out in the TCGA cohort, and 9 lncRNAs were shown to be significantly associated with prognosis. Least absolute shrinkage and selection operator (LASSO) regression analysis and multivariate Cox regression analysis were then used in the GEO cohort. 6 LRLs were identified as independent prognostic factors for ESCC patients used to construct a prognostic risk-related signature subsequently. Two groups were formed based on the middle value of risk scores: a low-risk group and a high-risk group. Following that, we conducted Kaplan-Meier survival analysis, which revealed that the high-risk group had a lower survival probability than the low-risk group in both GEO and TCGA cohorts. On multivariate Cox regression analysis, the prognostic signature was shown to be independent prognostic factor, and it was found to be a better predictor of the prognosis of ESCC patients than the currently widely used grading and staging approaches. The established nomogram can be conveniently applied in the clinic to predict the 1-, 3-, and 5- year survival rates of patients. There was a significant link found between the 6 LRLs-based prognostic signature and immune-cell infiltration, tumor microenvironment (TME), tumor somatic mutational status, and chemotherapeutic treatment sensitivity in the study population. Finally, we used GTEx RNA-seq data and qRT-PCR experiments to verify the expression levels of 6 LRLs. In conclusion, we constructed a prognostic signature which could predict the prognosis and immunotherapy response of ESCC patients.

摘要

乳酸,以前被认为是糖酵解的副产物或产生的代谢废物,现在已被确定为癌症生长、维持和进展的关键调节因子。然而,关于食管鳞状细胞癌(ESCC)中乳酸代谢相关长链非编码RNA(LRL)的研究结果仍无定论。在本研究中,对TCGA队列进行了单变量Cox回归分析,结果显示9种lncRNA与预后显著相关。随后在GEO队列中使用最小绝对收缩和选择算子(LASSO)回归分析和多变量Cox回归分析。6种LRL被确定为ESCC患者的独立预后因素,随后用于构建预后风险相关特征。根据风险评分的中位数分为两组:低风险组和高风险组。随后,我们进行了Kaplan-Meier生存分析,结果显示在GEO和TCGA队列中,高风险组的生存概率均低于低风险组。多变量Cox回归分析显示,预后特征是独立的预后因素,并且发现它比目前广泛使用的分级和分期方法更能预测ESCC患者的预后。所建立的列线图可方便地应用于临床,以预测患者的1年、3年和5年生存率。在研究人群中,基于6种LRL的预后特征与免疫细胞浸润、肿瘤微环境(TME)、肿瘤体细胞突变状态和化疗敏感性之间存在显著关联。最后,我们使用GTEx RNA-seq数据和qRT-PCR实验验证了6种LRL的表达水平。总之,我们构建了一个可以预测ESCC患者预后和免疫治疗反应的预后特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/17c053f53deb/fcell-10-845293-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/60599505db07/fcell-10-845293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/7ef1bfe7a65c/fcell-10-845293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/2d7468f53d21/fcell-10-845293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/b808294e80ed/fcell-10-845293-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/2c6971a7e7ec/fcell-10-845293-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/60b592770492/fcell-10-845293-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/e30ef96ff569/fcell-10-845293-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/961f2e53e05e/fcell-10-845293-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/dd2fa15fd479/fcell-10-845293-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/6dc7429fea8e/fcell-10-845293-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/17c053f53deb/fcell-10-845293-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/60599505db07/fcell-10-845293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/7ef1bfe7a65c/fcell-10-845293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/2d7468f53d21/fcell-10-845293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/b808294e80ed/fcell-10-845293-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/2c6971a7e7ec/fcell-10-845293-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/60b592770492/fcell-10-845293-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/e30ef96ff569/fcell-10-845293-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/961f2e53e05e/fcell-10-845293-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/dd2fa15fd479/fcell-10-845293-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/6dc7429fea8e/fcell-10-845293-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1e/9134121/17c053f53deb/fcell-10-845293-g011.jpg

相似文献

1
Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma.基于乳酸代谢相关长链非编码RNA的食管鳞状细胞癌患者风险特征识别
Front Cell Dev Biol. 2022 May 12;10:845293. doi: 10.3389/fcell.2022.845293. eCollection 2022.
2
The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.乳酸代谢相关长链非编码 RNA 在甲状腺乳头状癌预后、突变和肿瘤微环境中的作用。
Front Endocrinol (Lausanne). 2023 Mar 21;14:1062317. doi: 10.3389/fendo.2023.1062317. eCollection 2023.
3
Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.新型趋化因子相关长链非编码 RNA 标志物与食管鳞癌的预后、免疫图谱和治疗敏感性相关。
BMC Gastroenterol. 2023 Apr 20;23(1):132. doi: 10.1186/s12876-023-02688-5.
4
Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.基于长链非编码 RNA 的列线图识别可改善食管鳞癌预后预测。
Aging (Albany NY). 2020 Jan 24;12(2):1512-1526. doi: 10.18632/aging.102697.
5
Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.用于评估食管鳞状细胞癌患者免疫微环境、预后及治疗效果的瞬时受体电位(TRP)通道相关基因的综合分析
Front Cell Dev Biol. 2022 Mar 4;10:820870. doi: 10.3389/fcell.2022.820870. eCollection 2022.
6
Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.探讨外泌体相关长链非编码 RNA 对作为预测食管鳞癌免疫微环境、生存结局和微生物组景观的标志物的潜力。
Front Immunol. 2022 Jul 8;13:918154. doi: 10.3389/fimmu.2022.918154. eCollection 2022.
7
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.与食管鳞状细胞癌中M2巨噬细胞浸润相关的预后基因特征的开发与验证
Front Oncol. 2021 Dec 3;11:769727. doi: 10.3389/fonc.2021.769727. eCollection 2021.
8
Identification of mC-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients.鉴定 mC 相关 lncRNAs 特征,以预测食管鳞癌患者的预后和治疗反应。
Sci Rep. 2023 Sep 4;13(1):14499. doi: 10.1038/s41598-023-41495-6.
9
A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.成纤维细胞相关特征可预测食管鳞癌的预后和免疫治疗反应。
Front Immunol. 2023 May 29;14:1199040. doi: 10.3389/fimmu.2023.1199040. eCollection 2023.
10
Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.乳酸代谢相关 lncRNA 对:揭示结直肠腺癌患者免疫景观和介导治疗反应的预后标志物。
Front Immunol. 2022 Jul 11;13:881359. doi: 10.3389/fimmu.2022.881359. eCollection 2022.

引用本文的文献

1
Lactate-related gene signatures predict prognosis and immune profiles in esophageal squamous cell carcinoma.乳酸相关基因特征可预测食管鳞状细胞癌的预后和免疫特征。
Sci Rep. 2025 Jul 5;15(1):24032. doi: 10.1038/s41598-025-10456-6.
2
Lactate-related lncRNAs assessment model predicts the prognosis of pancreatic ductal adenocarcinoma.乳酸相关长链非编码RNA评估模型预测胰腺导管腺癌的预后。
Sci Rep. 2025 Jul 1;15(1):21226. doi: 10.1038/s41598-025-05486-z.
3
Sugemalimab plus chemotherapy vs. chemotherapy for treatment of Chinese patients with esophageal squamous cell carcinoma: a cost effectiveness analysis to inform decision making.

本文引用的文献

1
Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.脂肪酸代谢相关长链非编码RNA是预测结直肠癌患者总生存期的潜在生物标志物。
Front Oncol. 2021 Aug 11;11:704038. doi: 10.3389/fonc.2021.704038. eCollection 2021.
2
Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer.四种与预后相关的长链非编码RNA在卵巢癌中作为生物标志物
Front Genet. 2021 Jul 2;12:672674. doi: 10.3389/fgene.2021.672674. eCollection 2021.
3
TMEM161B-AS1 suppresses proliferation, invasion and glycolysis by targeting miR-23a-3p/HIF1AN signal axis in oesophageal squamous cell carcinoma.
舒格利单抗联合化疗与单纯化疗治疗中国食管鳞状细胞癌患者的成本效益分析:为决策提供信息
Front Oncol. 2025 Jun 5;15:1459695. doi: 10.3389/fonc.2025.1459695. eCollection 2025.
4
Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer.食管癌肿瘤免疫抑制微环境形成的机制。
World J Gastroenterol. 2024 Apr 28;30(16):2195-2208. doi: 10.3748/wjg.v30.i16.2195.
5
A four-gene signature predicts overall survival of patients with esophageal adenocarcinoma.一种四基因特征可预测食管腺癌患者的总生存期。
Transl Cancer Res. 2024 Mar 31;13(3):1382-1393. doi: 10.21037/tcr-23-1798. Epub 2024 Mar 7.
6
Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.鉴定与免疫原性细胞死亡相关的基因特征有助于预测肺腺癌的预后、免疫治疗疗效和肿瘤微环境。
Aging (Albany NY). 2024 Apr 3;16(7):6290-6313. doi: 10.18632/aging.205705.
7
A Risk Score Based on Immune- and Oxidative Stress-Related LncRNAs Predicts Prognosis in Lung Adenocarcinoma: Insights from in vitro Experiments and Large-Scale Transcriptome Analysis.基于免疫和氧化应激相关长链非编码RNA的风险评分预测肺腺癌预后:来自体外实验和大规模转录组分析的见解
J Inflamm Res. 2024 Mar 5;17:1453-1465. doi: 10.2147/JIR.S428287. eCollection 2024.
8
Warburg effect-related risk scoring model to assess clinical significance and immunity characteristics of glioblastoma.基于沃伯格效应的风险评分模型评估胶质母细胞瘤的临床意义和免疫特征。
Cancer Med. 2023 Nov;12(21):20639-20654. doi: 10.1002/cam4.6627. Epub 2023 Oct 21.
9
Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.新型趋化因子相关长链非编码 RNA 标志物与食管鳞癌的预后、免疫图谱和治疗敏感性相关。
BMC Gastroenterol. 2023 Apr 20;23(1):132. doi: 10.1186/s12876-023-02688-5.
10
Focus on pattern recognition receptors to identify prognosis and immune microenvironment in colon cancer.关注模式识别受体以识别结肠癌的预后和免疫微环境。
Front Oncol. 2022 Sep 23;12:1010023. doi: 10.3389/fonc.2022.1010023. eCollection 2022.
TMEM161B-AS1 通过靶向 miR-23a-3p/HIF1AN 信号轴抑制食管鳞癌细胞的增殖、侵袭和糖酵解。
J Cell Mol Med. 2021 Jul;25(14):6535-6549. doi: 10.1111/jcmm.16652. Epub 2021 May 27.
4
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤免疫微环境中与预后相关的糖酵解lncRNA特征的鉴定
Front Mol Biosci. 2021 Apr 22;8:645084. doi: 10.3389/fmolb.2021.645084. eCollection 2021.
5
LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma.长链非编码 RNA MIAT 与肝癌中的免疫浸润和药物反应相关。
Int Immunopharmacol. 2020 Dec;89(Pt A):107071. doi: 10.1016/j.intimp.2020.107071. Epub 2020 Nov 19.
6
Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade.了解食管癌:未来十年的挑战与机遇
Front Oncol. 2020 Sep 10;10:1727. doi: 10.3389/fonc.2020.01727. eCollection 2020.
7
Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China.5283 例食管癌患者的临床特征和生存分析:来自中国六个地区十八家医院的多中心研究。
Cancer Commun (Lond). 2020 Oct;40(10):531-544. doi: 10.1002/cac2.12087. Epub 2020 Aug 26.
8
Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.乳酸和乳酸转运蛋白作为维持瓦博格效应的关键因素。
Adv Exp Med Biol. 2020;1219:51-74. doi: 10.1007/978-3-030-34025-4_3.
9
Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.外泌体长链非编码 RNA ZFAS1 通过 microRNA-124/STAT3 轴调控食管鳞癌细胞的增殖、侵袭、迁移和凋亡。
J Exp Clin Cancer Res. 2019 Nov 27;38(1):477. doi: 10.1186/s13046-019-1473-8.
10
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.靶向葡萄糖代谢抑制肿瘤进展:抗糖酵解肿瘤治疗的前景。
Pharmacol Res. 2019 Dec;150:104511. doi: 10.1016/j.phrs.2019.104511. Epub 2019 Oct 31.